BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
2800363
Number of visits today
481
Number of downloads
2054499
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Benne N, Ter Braake D, Stoppelenburg AJ, Broere F. Nanoparticles for Inducing Antigen-Specific T Cell Tolerance in Autoimmune Diseases. Front Immunol 2022;13:864403. [PMID: 35392079 DOI: 10.3389/fimmu.2022.864403] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Firdessa Fite R, Bechi Genzano C, Mallone R, Creusot RJ. Epitope-based precision immunotherapy of Type 1 diabetes. Hum Vaccin Immunother 2023;19:2154098. [PMID: 36656048 DOI: 10.1080/21645515.2022.2154098] [Reference Citation Analysis]
2 Zala A, Thomas R. Antigen-specific immunotherapy to restore antigen-specific tolerance in Type 1 diabetes and Graves' disease. Clin Exp Immunol 2023;211:164-75. [PMID: 36545825 DOI: 10.1093/cei/uxac115] [Reference Citation Analysis]
3 Shuai Z, Zheng S, Wang K, Wang J, Leung PSC, Xu B. Reestablish immune tolerance in rheumatoid arthritis. Front Immunol 2022;13:1012868. [DOI: 10.3389/fimmu.2022.1012868] [Reference Citation Analysis]
4 Nepom GT. Synergistic targeting of immunologic pathways to empower durable tolerance therapies. Front Immunol 2022;13:962177. [DOI: 10.3389/fimmu.2022.962177] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345